USA – Halozyme Therapeutics has signed a definitive agreement to acquire all of Antares Pharma’s outstanding shares for nearly US$960 million in cash, or US$5.60 per share to further expand…
Read MoreHalozyme acquires Antares Pharma for US$960M to create drug delivery company
